Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine.

Francisella tularensis is the etiological agent of tularemia, a serious disease in several Northern hemisphere countries. The organism has fastidious growth requirements and is very poorly understood at the genetic and molecular levels. Given the lack of data on this organism, we undertook the sample sequencing of its genome. A random library of DNA fragments from a highly virulent strain (Schu 4) of F. tularensis was constructed and the nucleotide sequences of 13,904 cloned fragments were determined and assembled into 353 contigs. A total of 1.83 Mb of nucleotide sequence was obtained that had a G+C content of 33.2%. Genes located on plasmids pOM1 and pNFL10, which had been previously isolated from low virulence strains of F. tularensis, were absent but all of the other known F. tularensis genes were represented in the assembled data. F. tularensis Schu4 was able to grow in the absence of aromatic amino acids and orthologues of genes which could encode enzymes in the shikimate pathway in other bacteria were identified in the assembled data. Genes that could encode all of the enzymes in the purine biosynthetic and most of the en- zymes in the purine salvage pathways were also identified. This data will be used to develop defined rationally attenuated mutants of F. tularensis, which could be used as replacements for the existing genetically undefined live vaccine strain.

[1]  R. E. Chamberlain,et al.  EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM. , 1965, Applied microbiology.

[2]  N. W. Davis,et al.  The complete genome sequence of Escherichia coli K-12. , 1997, Science.

[3]  D. Burke Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. , 1977, The Journal of infectious diseases.

[4]  R. Fleischmann,et al.  Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. , 1995, Science.

[5]  B. Stocker,et al.  Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. , 1987, Microbial pathogenesis.

[6]  M. Schulman Purines and Pyrimidines , 1961 .

[7]  B. Stocker,et al.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines , 1981, Nature.

[8]  H. T. Eigelsbach,et al.  Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. , 1961, Journal of immunology.

[9]  C. W. Moss,et al.  Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease , 1989, Journal of clinical microbiology.

[10]  B. Stocker,et al.  Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves. , 1983, Developments in biological standardization.

[11]  B. E. Davidson,et al.  Analysis of an Escherichia coli mutant TyrR protein with impaired capacity for tyrosine‐mediated repression, but still able to activate atσ70 promoters , 1995, Molecular microbiology.

[12]  A. Tärnvik,et al.  Research articleEpidemiological analysis of tularemia in Sweden 1931–1993 , 1996 .

[13]  G. Dougan,et al.  Construction and characterization of vaccine strains of Salmonella harboring mutations in two different aro genes. , 1988, The Journal of infectious diseases.

[14]  M. Bernardini,et al.  Intracellular Multiplication and Virulence of Shigella flexneri Auxotrophic Mutants , 1998, Infection and Immunity.

[15]  I. Golovliov,et al.  Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. , 1995, Vaccine.

[16]  MJ Mahan,et al.  Selection of bacterial virulence genes that are specifically induced in host tissues , 1993, Science.

[17]  M. Forsman,et al.  Identification and classification of different isolates of Francisella tularensis. , 1993, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.

[18]  R. Gerloff,et al.  Deoxyribonucleic acid hybridization among some species of the genus Pasteurella , 1966, Journal of bacteriology.

[19]  T. Foster,et al.  Potency testing of a live, genetically attenuated vaccine for salmonids. , 1998, Vaccine.

[20]  H. Noda,et al.  Endosymbionts of ticks and their relationship to Wolbachia spp. and tick-borne pathogens of humans and animals , 1997, Applied and environmental microbiology.

[21]  G. Sandström The tularaemia vaccine. , 1994, Journal of chemical technology and biotechnology.

[22]  M. Homma,et al.  Epidemiological analysis of tularemia in Japan (yato-byo). , 1996, FEMS immunology and medical microbiology.

[23]  B. Gicquel,et al.  Persistence and Protective Efficacy of aMycobacterium tuberculosis Auxotroph Vaccine , 1999, Infection and Immunity.

[24]  R. Bentley,et al.  The shikimate pathway--a metabolic tree with many branches. , 1990, Critical reviews in biochemistry and molecular biology.

[25]  I. Charles,et al.  Gene expression and the development of live enteric vaccines. , 1990, Trends in biotechnology.

[26]  K. Elkins,et al.  Minimal requirements for murine resistance to infection with Francisella tularensis LVS , 1996, Infection and immunity.

[27]  A. Tärnvik,et al.  Epidemiological analysis of tularemia in Sweden 1931-1993. , 1996, FEMS immunology and medical microbiology.

[28]  A. Tärnvik,et al.  Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium , 1992, Infection and immunity.

[29]  B. Stocker Auxotrophic Salmonella typhi as live vaccine. , 1988, Vaccine.

[30]  A. Sjöstedt,et al.  Characterization and classification of strains of Francisella tularensis isolated in the central Asian focus of the Soviet Union and in Japan , 1992, Journal of clinical microbiology.

[31]  D. Maskell,et al.  Salmonella typhimurium aroB mutants are attentuated in BALB/c mice. , 1997, Microbial pathogenesis.

[32]  R. Titball,et al.  Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia. , 1995, Vaccine.

[33]  G. Dougan 1993 Colworth Prize Lecture. The molecular basis for the virulence of bacterial pathogens: implications for oral vaccine development. , 1994, Microbiology.

[34]  Cryptic plasmid pFNL10 from Francisella novicida-like F6168: the base of plasmid vectors for Francisella tularensis. , 1996, FEMS immunology and medical microbiology.

[35]  R. Titball,et al.  The efficacy of ciprofloxacin and doxycycline against experimental tularaemia. , 1998, The Journal of antimicrobial chemotherapy.

[36]  W. Braun,et al.  STUDIES ON THE VARIATION OF BACTERIUM TULARENSE , 1951, Journal of bacteriology.

[37]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[38]  G. Dougan,et al.  Construction of genetically defined double aro mutants of Salmonella typhi. , 1991, Vaccine.

[39]  B. Stocker,et al.  Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. , 1984, American journal of veterinary research.

[40]  A. Bateman The structure of a domain common to archaebacteria and the homocystinuria disease protein. , 1997, Trends in biochemical sciences.

[41]  M. Spence,et al.  Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium. , 1994, Vaccine.

[42]  R. Brubaker Interconversion of Purine Mononucleotides in Pasteurella pestis , 1970, Infection and immunity.

[43]  P. Scott,et al.  Safety and efficacy of two live Pasteurella multocida aro-A mutant vaccines in chickens. , 1999, Avian diseases.

[44]  T. Hadfield,et al.  Deletion of purE attenuates Brucella melitensis infection in mice , 1996, Infection and immunity.

[45]  P. Green,et al.  Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.

[46]  G. Dougan,et al.  Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice , 1988, Infection and immunity.

[47]  A. Dobozy,et al.  The growth of purine mutants of Bacillus anthracis in the body of the mouse. , 1968, Journal of general microbiology.

[48]  M. Homma,et al.  Arthropod-borne tularemia in Japan: clinical analysis of 1,374 cases observed between 1924 and 1996. , 1998, Journal of medical entomology.

[49]  B. Nichols,et al.  Characterization and sequence of Escherichia coli pabC, the gene encoding aminodeoxychorismate lyase, a pyridoxal phosphate-containing enzyme , 1992, Journal of bacteriology.

[50]  F. Neidhardt,et al.  Escherichia Coli and Salmonella: Typhimurium Cellular and Molecular Biology , 1987 .

[51]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[52]  P Green,et al.  Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.

[53]  A. Joachimiak,et al.  Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase. , 1999, Biochemistry.

[54]  R. Titball,et al.  An aroA mutant of Yersinia pestis is attenuated in guinea-pigs, but virulent in mice. , 1996, Microbiology.

[55]  B. Berdal,et al.  Field investigations of tularemia in Norway. , 1996, FEMS immunology and medical microbiology.

[56]  A. Sjöstedt,et al.  Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. , 1994, International journal of systematic bacteriology.